You are here

Article Text

Article menu

Download PDFPDF

Therapeutics/Prevention
Systematic review
Treatment of hepatitis C, then, now and tomorrow
Free
  1. Richard K Sterling,
  2. Narayan Dharel
  1. Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Medical Center, West Hospital, Richmond, Virginia, USA
  1. Correspondence to : Dr Richard K Sterling, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Medical Center, West Hospital, 14th Floor, 1200 East Broad Street, PO Box 980341, Richmond, VA 23298-0341, USA; rksterli{at}vcu.edu

https://doi.org/10.1136/ebmed-2014-110103

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Kohli A, Shaffer A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA 2014;312:631–40.OpenUrlCrossRefPubMedWeb of Science

    Context

    Hepatitis C virus (HCV) infects over 185 million people worldwide and can lead to progressive liver fibrosis, cirrhosis, hepatocellular carcinoma and death. Antiviral treatment can prevent these complications and improve survival. Interferon has been the backbone of anti-HCV therapy, but has been plagued by side effects, treatment failure and relapse. HCV treatment has seen significant changes with the advent of directly acting antiviral agents with nearly 100% cure rate with all oral, interferon and ribavirin-free regimens.

    Methods

    This systematic review of randomised controlled trials (RCTs) and cohort studies aimed to examine the safety, tolerability and efficacy of all Food and Drug Administration (FDA)-approved regimens against HCV genotypes 1, 2 and 3. All studies between January 2009 and May 2014 were included if they were published in English, used FDA-approved antiviral therapies, included sustained virological response (SVR) as the study outcome, and defined treatment …

    View Full Text